Literature DB >> 26435459

Value of transverse relaxometry difference methods for iron in human brain.

Md Nasir Uddin1, R Marc Lebel1, Alan H Wilman2.   

Abstract

PURPOSE: To investigate the brain iron dependence of transverse relaxation rate difference methods derived from spin echo and gradient echo measurements from two field strengths.
METHODS: Transverse relaxation rates R2 and R2(⁎) were measured in human brain in 17 healthy subjects at 1.5T and 4.7T using multi-slice, multiecho spin echo and gradient echo sequences. R2 quantification used stimulated echo compensation and R2(⁎) quantification used linear background gradient correction at 4.7T only. Subtraction of R2 from R2(⁎) within each field strength yielded R2('), and R2 subtraction across fields yielded Field Dependent R2 Increase (FDRI). All transverse relaxation measures were then correlated with published post-mortem iron concentrations using linear regression analysis. Regional differences were tested using paired t-tests. Phantom measurements of FDRI were also performed.
RESULTS: In deep grey matter, all transverse relaxation rates (R2, R2(⁎), R2(')) at both 1.5T and 4.7T, and FDRI had moderate to strong correlations (r>0.71, p<0.0001) with estimated non-heme iron. The 4.7T methods and FDRI had higher correlations (r>0.9) than 1.5T measures. R2, R2(⁎), R2' at 4.7T and FDRI had slopes 0.49, 1.96, 1.48 and 0.33 [s(-1)/mg Fe/100g wt. tissue] and intercepts 14.40, 16.87, 2.47 and 3.21 [s(-1)] respectively. Even though FDRI yielded a zero intercept in phantom, in vivo FDRI was found to be ineffective at fully removing non-iron contributions and yielded a large intercept. The slope for R2(') was 3.4 times greater at 4.7T than 1.5T. For white matter fiber tracts oriented predominantly perpendicular versus parallel to B0, R2(') increased by ~50% at 4.7T and ~30% at 1.5T, while R2 and FDRI in white matter was insensitive to its orientation with respect to B0.
CONCLUSION: The transverse relaxation difference methods FDRI and R2(') at 4.7T had high correlations to predicted iron content similar to R2 and R2(⁎) at 4.7T. Although R2(') had smaller y-intercept with estimated iron concentration than FDRI, in white matter R2(') demonstrated strongest dependence on fiber orientation with respect to B0. These results suggest that for brain iron correlation, there is minimal value of transverse difference methods over a single R2(⁎) measurement at highest available field, which was 4.7T.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FDRI; Iron; R(2)(’); Stimulated echo compensation; Transverse relaxometry

Mesh:

Substances:

Year:  2015        PMID: 26435459     DOI: 10.1016/j.mri.2015.09.002

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  4 in total

1.  MR imaging differentiation of Fe2+ and Fe3+ based on relaxation and magnetic susceptibility properties.

Authors:  Olaf Dietrich; Johannes Levin; Seyed-Ahmad Ahmadi; Annika Plate; Maximilian F Reiser; Kai Bötzel; Armin Giese; Birgit Ertl-Wagner
Journal:  Neuroradiology       Date:  2017-03-21       Impact factor: 2.804

2.  Heritability of R2* iron in the basal ganglia and cortex.

Authors:  Edith Hofer; Lukas Pirpamer; Christian Langkammer; Christian Tinauer; Sudha Seshadri; Helena Schmidt; Reinhold Schmidt
Journal:  Aging (Albany NY)       Date:  2022-08-09       Impact factor: 5.955

3.  In vivo measurements of irreversible and reversible transverse relaxation rates in human basal ganglia at 7 T: making inferences about the microscopic and mesoscopic structure of iron and calcification deposits.

Authors:  Mukund Balasubramanian; Jonathan R Polimeni; Robert V Mulkern
Journal:  NMR Biomed       Date:  2019-07-19       Impact factor: 4.044

4.  Quantitative Ex Vivo MRI Changes due to Progressive Formalin Fixation in Whole Human Brain Specimens: Longitudinal Characterization of Diffusion, Relaxometry, and Myelin Water Fraction Measurements at 3T.

Authors:  Anwar S Shatil; Md Nasir Uddin; Kant M Matsuda; Chase R Figley
Journal:  Front Med (Lausanne)       Date:  2018-02-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.